Seven Biopharma Trends to Watch in 2025

Abstract

Get full access to this article

View all access options for this article.

References

Philippidis

. Exscientia Fires CEO for “Inappropriate” Relationships with Two Employees. 2024. Available from: https://www.genengnews.com/topics/artificial-intelligence/exscientia-fires-ceo-for-inappropriate-relationships-with-two-employees/ [Last accessed: January 20, 2025].

Philippidis

. Insilico Details AI-Designed IBD Candidate’s Path to Nomination. 2024. Available from: https://www.genengnews.com/topics/artificial-intelligence/insilico-details-ai-designed-ibd-candidates-path-to-nomination/ [Last accessed: January 20, 2025].

Philippidis

. Insilico Plans Pivotal Trial for AI-Based IPF Candidate. 2024. Available from: https://www.genengnews.com/topics/artificial-intelligence/insilico-plans-pivotal-trial-for-ai-based-ipf-candidate/ [Last accessed: January 20, 2025].

Chiauhan

. Here’s Why Nvidia Stock Could Double in 2025. 2024. Available from: https://www.fool.com/investing/2024/12/28/heres-why-nvidia-stock-could-double-in-2025/ [Last accessed: January 20, 2025].

Ye-Won

, Tsmc Starts US. Production in Q1 2024, Expects Price Hike Due to Costs. 2024. Available from: https://biz.chosun.com/en/en-it/2024/12/29/ADBYND4LENHYNF7R3SFGCZ75SM/ [Last accessed: January 20, 2025].

Q3 2024 Biopharma Licensing and Venture Report. 2024. Available from: https://www.jpmorgan.com/content/dam/jpmorgan/documents/cb/insights/outlook/jpm-biopharma-deck-q3-2024-final-ada.pdf [Last accessed: January 20, 2025].

AI Drug Developer Xaira Therapeutics Launches with $1B+. 2024. Available from: https://www.genengnews.com/topics/artificial-intelligence/ai-drug-developer-xaira-therapeutics-launches-with-1b/ [Last accessed: January 20, 2025].

Philippidis

. StockWatch: IPO Revival? CG Oncology, ArriVent Raise a Combined $555M. 2024. Available from: https://www.genengnews.com/topics/cancer/stockwatch-ipo-revival-cg-oncology-arrivent-raise-a-combined-555m/ [Last accessed: January 20, 2025].

Urnov

. Give cas a chance: An actionable path to a platform for CRISPR Cures. Crispr J, 2024; 7(5):212–219; doi: 10.1089/crispr.2024.0082

10.

Philippidis

. Horizontal DNA double helix FDA clears prime Medicine’s IND FOR first prime editing therapy. 2024. Available from: https://www.genengnews.com/topics/genome-editing/fda-clears-prime-medicines-ind-for-first-prime-editing-therapy/ [Last accessed: January 20, 2025].

11.

Wave Clinical Trial Shows First Successful RNA Editing in Humans. 2024. Available from: https://www.genengnews.com/topics/genome-editing/wave-clinical-trial-shows-first-successful-rna-editing-in-humans/ [Last accessed: January 20, 2025].

12.

StockWatch. Antitrust Fears Dampen Support for $43B Pfizer-Seagen Deal. 2024. Available from: https://www.genengnews.com/news/stockwatch-antitrust-fears-dampen-support-for-43b-pfizer-seagen-deal/ [Last accessed: January 20, 2025].

13.

Philippidis

. Vertex to Acquire Alpine Immune Sciences for $4.9B, Broadening Kidney Drug Pipeline. 2024. Available from: https://www.genengnews.com/topics/drug-discovery/vertex-to-acquire-alpine-immune-sciences-for-4-9b-broadening-kidney-drug-pipeline/ [Last accessed: January 20, 2025].

14.

Philippidis

. StockWatch: As Illumina Expands in Multiomics, Analyst Sees Threat to 10x. 2024. Available from: https://www.genengnews.com/topics/omics/stockwatch-as-illumina-expands-in-multiomics-analyst-sees-threat-to-10x/ [Last accessed: January 20, 2025].

15.

LeMieux

. Illumina’s Jacob Thaysen Describes His First Year as CEO. 2024. Available from: https://www.genengnews.com/topics/omics/illuminas-jacob-thaysen-describes-his-first-year-as-ceo/ [Last accessed: January 20, 2025].

16.

Philippidis

. Vizgen, Ultivue Merge, Further Consolidating Spatial Biology. 2024. Available from: https://www.genengnews.com/topics/omics/vizgen-ultivue-merge-further-consolidating-spatial-biology/ [Last accessed: January 20, 2025].

17.

Philippidis

. Bruker to Acquire NanoString with $392.6M Winning Bid. 2024. Available from: https://www.genengnews.com/topics/omics/bruker-to-acquire-nanostring-with-392-6m-winning-bid/ [Last accessed: January 20, 2025].

18.

NanoString Files for Chapter 11 Bankruptcy, Launches Strategic Review. 2024. Available from: https://www.genengnews.com/news/nanostring-files-for-chapter-11-bankruptcy-launches-strategic-review/ [Last accessed: January 20, 2025].

19.

Orr

, Kulasinghe

, Kolar

, et al. Sounding an Alarm over Spatial Biology. 2024. Available from: https://www.genengnews.com/insights/sounding-an-alarm-over-spatial-biology/ [Last accessed: January 20, 2025].

20.

Philippidis

. 10x, Bruker Launch New Single Cell Products. 2024. Available from: https://www.genengnews.com/topics/omics/10x-bruker-launch-new-single-cell-products/ [Last accessed: January 20, 2025].

21.

Philippidis

. StockWatch: Vaccine, ETF Shares Drop as Trump Chooses RFK Jr. for HHS. 2024. Available from: https://www.genengnews.com/topics/drug-discovery/stockwatch-vaccine-etf-shares-drop-as-trump-chooses-rfk-jr-for-hhs/ [Last accessed: January 20, 2025].

22.

Philippidis

. Seven Biopharma Trends to Watch in 2025. 2024. Available from: https://www.genengnews.com/insights/trends-for-2025/seven-biopharma-trends-to-watch-in-2025/ [Last accessed: January 20, 2025].